Status:
RECRUITING
A Non-interventional Study With Advanced Lung Squamous Cell Carcinoma
Lead Sponsor:
Hunan Province Tumor Hospital
Conditions:
Advanced Lung Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recrui...
Eligibility Criteria
Inclusion
- Patients must be ≥18 years.
- Provision of fully informed consent prior to any study specific procedures.
- Advanced or metastatic lung squamous cell carcinoma confirmed by histology or cytology.
- According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.
Exclusion
- None
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05984017
Start Date
July 1 2021
End Date
December 31 2025
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yongchang Zhang
Changsha, Hunan, China, 410013